ArticleIJU case reports2022

Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma.

Hiroki Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.